MA
ABBV icon

Momentum Advisors’s AbbVie ABBV Stock Holding History

Momentum Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$204K Buy
+1,261
New +$193K 0.21% 80

Other funds holding ABBV

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Momentum Advisors's ABBV Position: Q4 2022 in Review

Momentum Advisors opened a new position in AbbVie (ABBV) in Q4 2022: 1,261 shares worth $204K. The stake represents 0.21% of the portfolio and ranks #80 among its holdings.

3,167 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.

  • Momentum Advisors held 1,261 shares of AbbVie worth $204K as of Q4 2022.
  • AbbVie was a new Momentum Advisors position in Q4 2022.
  • AbbVie made up 0.21% of Momentum Advisors's portfolio in Q4 2022, its #80 holding.
  • 3,167 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.

Based on Momentum Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.